Home > Boards > US Listed > Medical - Healthcare > Gilead Sciences, Inc. (GILD)

https://www.otcmarkets.com/stock/GILD/disclosure

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
mick Member Profile
Member Level 
Followed By 2,793
Posts 890,130
Boards Moderated 350
Alias Born 09/04/00
160x600 placeholder
Gilead Sciences Up Nearly 7%, Best Performer in the Nasdaq 100 So Far Today -- Data Talk Dow Jones News - 1/19/2021 12:07:00 PM
Francesco M. Marincola Joins Kite as Worldwide Head of Cell Therapy Research Business Wire - 1/19/2021 8:00:00 AM
Gilead and Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chron... GlobeNewswire Inc. - 1/12/2021 8:00:00 AM
Gilead & Vir Biotechnology Establish Clinical Collaboration to Explore Combination Strategies for Functional Cure for Chronic... Business Wire - 1/12/2021 8:00:00 AM
Gilead Lifts 2020 Guidance Driven By Remdesivir Demand; Shares Gain TipRanks - 1/11/2021 10:35:37 AM
Eli Lilly, Twitter, NIO: What to Watch When the Stock Market Opens Today Dow Jones News - 1/11/2021 8:12:00 AM
Gilead Raises Product Sales Guidance on Remdesivir Demand, Narrows Earnings Outlook for 2020 Dow Jones News - 1/11/2021 7:03:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/11/2021 6:05:36 AM
Gilead Sciences Announces Updated 2020 Guidance Business Wire - 1/11/2021 6:00:00 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 1/6/2021 5:26:18 PM
Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors Business Wire - 1/6/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/4/2021 1:25:26 PM
Gilead Sciences or Biogen: Which Biotech Stock is a Better Pick for 2021? TipRanks - 1/3/2021 3:58:28 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/29/2020 3:09:53 PM
Gilead Sciences to Present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 Business Wire - 12/21/2020 4:01:00 PM
Galapagos Shares Drop 19% After Gilead Won't Seek FDA Approval for Jyseleca Dow Jones News - 12/16/2020 1:21:00 PM
Gilead, Galapagos Amend Arrangement on Jyseleca; Gilead Won't Pursue FDA Approval Dow Jones News - 12/16/2020 8:04:00 AM
Kite’s Tecartus™ (KTE-X19) Granted Conditional Marketing Authorization for the Treatment of Relapsed or Refractory Mantle... Business Wire - 12/16/2020 3:01:00 AM
Gilead and Galapagos Announce New Commercialization and Development Agreement for Jyseleca® (Filgotinib) Business Wire - 12/15/2020 4:15:00 PM
Gilead Advances Oncology Portfolio With New Data From Phase 3 ASCENT Trial of Trodelvy® in Metastatic Triple Negative Breast... Business Wire - 12/10/2020 4:48:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/10/2020 4:11:13 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/10/2020 4:08:10 PM
Gilead Sciences to Acquire MYR GmbH PR Newswire (US) - 12/10/2020 9:20:00 AM
Gilead to Pay $1.4 Billion for Hepatitis Drug Maker MYR GmbH of Germany Dow Jones News - 12/10/2020 8:29:00 AM
Gilead Sciences to Acquire MYR GmbH Business Wire - 12/10/2020 8:00:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2021 InvestorsHub.com, Inc.
Consent Preferences